CC
EW icon

Cipher Capital’s Edwards Lifesciences EW Stock Holding History

Cipher Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,084
Closed -$291K – 411
2023
Q2 		$291K Buy
+3,084
New +$268K 0.05% 411
2013
Q4 		– Sell
-26,196
Closed -$304K – 318
2013
Q3 		$304K Buy
+26,196
New +$306K 0.42% 101

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cipher Capital's EW Position: Q3 2023 in Review

Cipher Capital sold out of Edwards Lifesciences (EW) in Q3 2023, closing a stake of 3,084 shares — an estimated $291K sold.

Cipher Capital first reported a position in EW in Q3 2013 and held it in 2 quarters. The position peaked at $304K in Q3 2013. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Cipher Capital reported no remaining Edwards Lifesciences position as of Q3 2023 after selling out during the quarter.
  • Cipher Capital sold 3,084 Edwards Lifesciences shares in Q3 2023, an estimated $291K.
  • Cipher Capital first reported a position in Edwards Lifesciences in Q3 2013 and held it in 2 quarters.
  • Cipher Capital's Edwards Lifesciences position peaked at $304K in Q3 2013.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Cipher Capital's 13F filing for Q3 2023, filed 14 Nov 2023.